Boston Scientific (NYSE:BSX) Surprises With Q1 CY2026 Sales [Yahoo! Finance]
Boston Scientific Corporation (BSX)
Last boston scientific corporation earnings: 4/29 06:30 am
Check Earnings Report
US:NYSE Investor Relations:
investors.bostonscientific.com
Company Research
Source: Yahoo! Finance
On the other hand, next quarter's revenue guidance of $5.39 billion was less impressive, coming in 2.9% below analysts' estimates. Its non-GAAP profit of $0.80 per share was 1.6% above analysts' consensus estimates. Is now the time to buy Boston Scientific? Find out in our full research report Boston Scientific (BSX) Q1 CY2026 Highlights: Revenue: $5.20 billion vs analyst estimates of $5.18 billion (11.6% year-on-year growth, 0.5% beat) Adjusted EPS: $0.80 vs analyst estimates of $0.79 (1.6% beat) Adjusted Operating Income: $1.10 billion vs analyst estimates of $1.45 billion (21.2% margin, 24.2% miss) Revenue Guidance for Q2 CY2026 is $5.39 billion at the midpoint, below analyst estimates of $5.55 billion Management lowered its full-year Adjusted EPS guidance to $3.38 at the midpoint, a 2.5% decrease Operating Margin: 21.2%, up from 19.8% in the same quarter last year Organic Revenue rose 9.4% year on year (beat) Market Capitalization: $88.46 billion "Our global
Show less
Read more
Impact Snapshot
Event Time:
BSX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BSX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BSX alerts
High impacting Boston Scientific Corporation news events
Weekly update
A roundup of the hottest topics
BSX
News
- BSX Q1 2026 Earnings Transcript [Globe and Mail, The (Toronto, Canada)]Globe and Mail, The
- BSX Q3 2025 Earnings Transcript [Globe and Mail, The (Toronto, Canada)]Globe and Mail, The
- Boston Scientific (BSX) had its price target lowered by Barclays PLC from $124.00 to $100.00. They now have an "overweight" rating on the stock.MarketBeat
- Boston Scientific cuts 2026 profit forecast, trims revenue growth view [BNN Bloomberg (Canada)]BNN Bloomberg
- BSX DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Boston Scientific (BSX) Investors of Securities Class Action Deadline on May 4, 2026Business Wire
BSX
Earnings
- 4/22/26 - In-Line
BSX
Sec Filings
- 4/22/26 - Form 8-K
- 4/2/26 - Form EFFECT
- 4/1/26 - Form 424B3
- BSX's page on the SEC website